USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
We assign a fundamental rating of 5 out of 10 to HLN. HLN was compared to 190 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are some minor concerns on its financial health. HLN has a valuation in line with the averages, but it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.33 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 17.74 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.07 | ||
| EV/EBITDA | 15.35 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
ChartMill assigns a valuation rating of 5 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.74 and the Price/Book (PB) ratio is 2.09.
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.